- 全部删除
- 您的购物车当前为空
Compound 12c has been synthesized with modifications to the Cap group and exhibits broad-spectrum enzyme inhibitory activity as evidenced by enzyme inhibition assays. Compounds 9m and 9q show a preference for inhibiting HDAC6, demonstrating selective inhibitory activity among representative subtypes.
Compound 12c has been synthesized with modifications to the Cap group and exhibits broad-spectrum enzyme inhibitory activity as evidenced by enzyme inhibition assays. Compounds 9m and 9q show a preference for inhibiting HDAC6, demonstrating selective inhibitory activity among representative subtypes.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 8-10周 | |
50 mg | ¥ 13,800 | 8-10周 | |
100 mg | ¥ 17,500 | 8-10周 |
HDAC6-IN-8 相关产品
产品描述 | Compound 12C, modified by altering cap groups, exhibits broad-spectrum enzyme inhibitory activity, as demonstrated in enzyme inhibition assays. Conversely, compounds 9m and 9q display a predilection towards HDAC6 inhibition, indicating subtype-selective inhibitory properties among the tested variants. |
分子量 | 510.32 |
分子式 | C23H17BrFN5O3 |
CAS No. | 2796282-49-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容